BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 19124382)

  • 1. Antioxidant therapeutic advances in COPD.
    Rahman I
    Ther Adv Respir Dis; 2008 Dec; 2(6):351-74. PubMed ID: 19124382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
    Biswas S; Hwang JW; Kirkham PA; Rahman I
    Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant therapies in COPD.
    Rahman I
    Int J Chron Obstruct Pulmon Dis; 2006; 1(1):15-29. PubMed ID: 18046899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant therapeutic targets in COPD.
    Rahman I; Kilty I
    Curr Drug Targets; 2006 Jun; 7(6):707-20. PubMed ID: 16787173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological antioxidant strategies as therapeutic interventions for COPD.
    Rahman I
    Biochim Biophys Acta; 2012 May; 1822(5):714-28. PubMed ID: 22101076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant pharmacological therapies for COPD.
    Rahman I; MacNee W
    Curr Opin Pharmacol; 2012 Jun; 12(3):256-65. PubMed ID: 22349417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidants and mucolytics in COPD management: when (if ever) and in whom?
    Hillas G; Nikolakopoulou S; Hussain S; Vassilakopoulos T
    Curr Drug Targets; 2013 Feb; 14(2):225-34. PubMed ID: 23256719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and redox regulation of lung inflammation in COPD.
    Rahman I; Adcock IM
    Eur Respir J; 2006 Jul; 28(1):219-42. PubMed ID: 16816350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD.
    Cazzola M; Page CP; Wedzicha JA; Celli BR; Anzueto A; Matera MG
    Respir Res; 2023 Jul; 24(1):194. PubMed ID: 37517999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.
    Dailah HG
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress-based therapeutics in COPD.
    Barnes PJ
    Redox Biol; 2020 Jun; 33():101544. PubMed ID: 32336666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation pathway and exacerbations in COPD: the role of NAC.
    Matera MG; Calzetta L; Cazzola M
    Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.
    Rahman I; Kinnula VL
    Expert Rev Clin Pharmacol; 2012 May; 5(3):293-309. PubMed ID: 22697592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.
    Malhotra D; Thimmulappa R; Navas-Acien A; Sandford A; Elliott M; Singh A; Chen L; Zhuang X; Hogg J; Pare P; Tuder RM; Biswal S
    Am J Respir Crit Care Med; 2008 Sep; 178(6):592-604. PubMed ID: 18556627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine.
    Santus P; Corsico A; Solidoro P; Braido F; Di Marco F; Scichilone N
    COPD; 2014 Dec; 11(6):705-17. PubMed ID: 24787454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPD: balancing oxidants and antioxidants.
    Fischer BM; Voynow JA; Ghio AJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():261-76. PubMed ID: 25673984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting oxidant-dependent mechanisms for the treatment of respiratory diseases and their comorbidities.
    Thomson NC
    Curr Opin Pharmacol; 2018 Jun; 40():1-8. PubMed ID: 29223018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and free radicals in COPD--implications and relevance for treatment.
    Domej W; Oettl K; Renner W
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1207-24. PubMed ID: 25378921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
    Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
    Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crocin attenuates cigarette smoke-induced lung injury and cardiac dysfunction by anti-oxidative effects: the role of Nrf2 antioxidant system in preventing oxidative stress.
    Dianat M; Radan M; Badavi M; Mard SA; Bayati V; Ahmadizadeh M
    Respir Res; 2018 Apr; 19(1):58. PubMed ID: 29631592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.